← Leaderboards
Sathyanarayana Janardhanan
Rise Therapeutics, Llc
$688,972
Attributed
$1,377,944
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $704.6K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,377,944 · 1
By mechanism
SB1$1,377,944 · 1
Top collaborators
- Gary Fanger2 shared
Most similar at Rise Therapeutics, Llc
Same institution · by research overlap
- Gary Fanger$26,547,866
- Christian Furlan Freguia$4,372,588
Others in their field
Other Rising Stars on “Analytical Method”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Supriya Menezes · The Emmes Company, Llc$18,307,989
- Kevin V Grimes · Stanford University$14,783,804
- Atul Butte$13,028,424
- Venkata Mangalampalli · Leidos Biomedical Research, Inc.$11,756,555
- Sophia Zanakos · Icf, Inc., Llc$10,014,539
Research focus
Analytical MethodAnimal ModelAnti-Inflammatory AgentsBacteriaBindingBiologicalBiological MarkersBioprocessCapsuleCell Adhesion MoleculesCell LineCell PhysiologyCellsChronic Inflammatory DiseaseClimactericClinical DevelopmentClinical DistributionClinical ProtocolsClinical Research SiteClinical TrialsColitisCommensal BacteriaCommercializationAdult